Abstract
Limb-girdle muscular dystrophy type 2O (LGMD2O) belongs to a group of rare muscular dystrophies named dystroglycanopathies, which are characterized molecularly by hypoglycosylation of α-dystroglycan (α-DG). Here, we describe the first dystroglycanopathy patient carrying an alteration in the promoter region of the POMGNT1 gene (protein O-mannose β-1,2-N-acetylglucosaminyltransferase 1), which involves a homozygous 9-bp duplication (-83_-75dup). Analysis of the downstream effects of this mutation revealed a decrease in the expression of POMGNT1 mRNA and protein because of negative regulation of the POMGNT1 promoter by the transcription factor ZNF202 (zinc-finger protein 202). By functional analysis of various luciferase constructs, we localized a proximal POMGNT1 promoter and we found a 75% decrease in luciferase activity in the mutant construct when compared with the wild type. Electrophoretic mobility shift assay (EMSA) revealed binding sites for the Sp1, Ets1 and GATA transcription factors. Surprisingly, the mutation generated an additional ZNF202 binding site and this transcriptional repressor bound strongly to the mutant promoter while failing to recognize the wild-type promoter. Although the genetic causes of dystroglycanopathies are highly variable, they account for only 50% of the cases described. Our results emphasize the importance of extending the mutational screening outside the gene-coding region in dystroglycanopathy patients of unknown aetiology, because mutations in noncoding regions may be the cause of disease. Our findings also underline the requirement to perform functional studies that may assist the interpretation of the pathogenic potential of promoter alterations.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
References
Godfrey C, Foley AR, Clement E, Muntoni F : Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 2011; 21: 278–285.
Hewitt JE : Abnormal glycosylation of dystroglycan in human genetic disease. Biochim Biophys Acta 2009; 1792: 853–861.
Campbell KP : Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995; 80: 675–679.
Manya H, Chiba A, Yoshida A et al: Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci USA 2004; 101: 500–505.
Yoshida A, Kobayashi K, Manya H et al: Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001; 1: 717–724.
Muntoni F, Torelli S, Brockington M : Muscular dystrophies due to glycosylation defects. Neurotherapeutics 2008; 5: 627–632.
Manya H, Sakai K, Kobayashi K et al: Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. Biochem Biophys Res Commun 2003; 306: 93–97.
Taniguchi K, Kobayashi K, Saito K et al: Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum Mol Genet 2003; 12: 527–534.
Clement EM, Godfrey C, Tan J et al: Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol 2008; 65: 137–141.
Guglieri M, Straub V, Bushby K, Lochmuller H : Limb-girdle muscular dystrophies. Curr Opin Neurol 2008; 21: 576–584.
Martin JJ, Ceuterick C, Van Goethem G : On a dominantly inherited myopathy with tubular aggregates. Neuromuscul Disord 1997; 7: 512–520.
Nordeen SK : Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 1988; 6: 454–458.
Lou G, Li Y, Chen B et al: Functional analysis on the 5′-flanking region of human FXR gene in HepG2 cells. Gene 2007; 396: 358–368.
Lennon G, Auffray C, Polymeropoulos M, Soares MB : The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 1996; 33: 151–152.
Won J, Yim J, Kim TK : Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 2002; 277: 38230–38238.
Wagner S, Hess MA, Ormonde-Hanson P et al: A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J Biol Chem 2000; 275: 15685–15690.
Brown SC, Torelli S, Brockington M et al: Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol 2004; 164: 727–737.
Jimenez-Mallebrera C, Torelli S, Feng L et al: A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol 2009; 19: 596–611.
Smale ST, Schmidt MC, Berk AJ, Baltimore D : Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci USA 1990; 87: 4509–4513.
Jolliff K, Li Y, Johnson LF : Multiple protein-DNA interactions in the TATAA-less mouse thymidylate synthase promoter. Nucleic Acids Res 1991; 19: 2267–2274.
Sharrocks AD : The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2001; 2: 827–837.
Pengue G, Lania L : Kruppel-associated box-mediated repression of RNA polymerase II promoters is influenced by the arrangement of basal promoter elements. Proc Natl Acad Sci USA 1996; 93: 1015–1020.
Acknowledgements
We thank Cristina Lendínez and Belén García for their excellent technical assistance, and Mark Sefton for critical reading of the manuscript. This work was supported by a grant from the Fondo de Investigaciones Sanitarias (PI09/0343). MR is supported by a FPU-UAM fellowship. JB is supported by a fellowship of the Fund for Scientific Research (FWO-Flanders).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Rights and permissions
About this article
Cite this article
Raducu, M., Baets, J., Fano, O. et al. Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O. Eur J Hum Genet 20, 945–952 (2012). https://doi.org/10.1038/ejhg.2012.40
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2012.40
Keywords
This article is cited by
-
Evolution of protein N-glycosylation process in Golgi apparatus which shapes diversity of protein N-glycan structures in plants, animals and fungi
Scientific Reports (2017)
-
Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencing
Scientific Reports (2017)
-
Limb-girdle muscular dystrophies — international collaborations for translational research
Nature Reviews Neurology (2016)
